User menu

(89)Zr-labelled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.

Bibliographic reference Karmani, Linda ; Bouchat, Virginie ; Bouzin, Caroline ; Levêque, Philippe ; Labar, Daniel ; et. al. (89)Zr-labelled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.. In: Nanomedicine, Vol. 9, no. 13, p. 1923-1937 (2014)
Permanent URL http://hdl.handle.net/2078.1/141002
  1. Wang J. M., Kumar S., Pye D., Krupinski J., Hunter R. D., Van Agthoven A. J., A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues, 10.1002/ijc.2910540303
  2. Fonsatti Ester, Vecchio Luigi Del, Altomonte Maresa, Sigalotti Luca, Nicotra Maria Rita, Coral Sandra, Natali Pier Giorgio, Maio Michele, Endoglin: An accessory component of the TGF-?-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies, 10.1002/jcp.1095
  3. Rosen L. S., Hurwitz H. I., Wong M. K., Goldman J., Mendelson D. S., Figg W. D., Spencer S., Adams B. J., Alvarez D., Seon B. K., Theuer C. P., Leigh B. R., Gordon M. S., A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer, 10.1158/1078-0432.ccr-12-0098
  4. Raoof, Int. J. Hepatol., 676957 (2011)
  5. Hainfeld James F, Slatkin Daniel N, Smilowitz Henry M, The use of gold nanoparticles to enhance radiotherapy in mice, 10.1088/0031-9155/49/18/n03
  6. Chang Meng-Ya, Shiau Ai-Li, Chen Yu-Hung, Chang Chih-Jui, Chen Helen H-W, Wu Chao-Liang, Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice, 10.1111/j.1349-7006.2008.00827.x
  7. Moran Christine H., Wainerdi Sean M., Cherukuri Tonya K., Kittrell Carter, Wiley Benjamin J., Nicholas Nolan W., Curley Steven A., Kanzius John S., Cherukuri Paul, Size-dependent joule heating of gold nanoparticles using capacitively coupled radiofrequency fields, 10.1007/s12274-009-9048-1
  8. Glazer Evan S., Curley Steven A., Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles, 10.1002/cncr.25135
  9. Abou Diane S., Ku Thomas, Smith-Jones Peter M., In vivo biodistribution and accumulation of 89Zr in mice, 10.1016/j.nucmedbio.2010.12.011
  10. MEALEY JOHN, Turn-over of Carrier-free Zirconium-89 in Man, 10.1038/179673a0
  11. Tinianow Jeff N., Gill Herman S., Ogasawara Annie, Flores Judith E., Vanderbilt Alexander N., Luis Elizabeth, Vandlen Richard, Darwish Martine, Junutula Jagath R., Williams Simon-P., Marik Jan, Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET, 10.1016/j.nucmedbio.2009.11.010
  12. De Jong Wim H., Hagens Werner I., Krystek Petra, Burger Marina C., Sips Adriënne J.A.M., Geertsma Robert E., Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, 10.1016/j.biomaterials.2007.12.037
  13. Mahmoud Marwa, Borthwick Gillian M, Hislop Alison A, Arthur Helen M, Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH, 10.1038/labinvest.2008.112
  14. He Chunbai, Hu Yiping, Yin Lichen, Tang Cui, Yin Chunhua, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, 10.1016/j.biomaterials.2010.01.065
  15. Videira Mafalda A., Botelho M.F., Santos Ana C., Gouveia Luis F., Pedroso de Lima J.J., Almeida António J., Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles, 10.1080/1061186021000054933
  16. Hirota Keiji, Hasegawa Taizo, Hinata Hideyuki, Ito Fuminori, Inagawa Hiroyuki, Kochi Chie, Soma Gen-Ichiro, Makino Kimiko, Terada Hiroshi, Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages, 10.1016/j.jconrel.2007.01.013
  17. Garnett M. C., Kallinteri P., Nanomedicines and nanotoxicology: some physiological principles, 10.1093/occmed/kql052
  18. Alkilany Alaaldin M., Murphy Catherine J., Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?, 10.1007/s11051-010-9911-8
  19. Huisman Marc C., Reder Sybille, Weber Axel W., Ziegler Sibylle I., Schwaiger Markus, Performance evaluation of the Philips MOSAIC small animal PET scanner, 10.1007/s00259-006-0271-7
  20. Hong Hao, Yang Yunan, Zhang Yin, Engle Jonathan W., Barnhart Todd E., Nickles Robert J., Leigh Bryan R., Cai Weibo, Positron emission tomography imaging of CD105 expression during tumor angiogenesis, 10.1007/s00259-011-1765-5
  21. Masereel Bernard, Dinguizli Mustapha, Bouzin Caroline, Moniotte Nicolas, Feron Olivier, Gallez Bernard, Vander Borght Thierry, Michiels Carine, Lucas Stéphane, Antibody immobilization on gold nanoparticles coated layer-by-layer with polyelectrolytes, 10.1007/s11051-010-9908-3
  22. Moreau Nicolas, Michiels Carine, Masereel Bernard, Feron Olivier, Gallez Bernard, Vander Borght Thierry, Lucas Stéphane, PVD Synthesis and Transfer into Water-Based Solutions of Functionalized Gold Nanoparticles, 10.1002/ppap.200932210
  23. Perk Lars R., Vosjan Maria J. W. D., Visser Gerard W. M., Budde Marianne, Jurek Paul, Kiefer Garry E., van Dongen Guus A. M. S., p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging, 10.1007/s00259-009-1263-1
  24. Vosjan Maria J W D, Perk Lars R, Visser Gerard W M, Budde Marianne, Jurek Paul, Kiefer Garry E, van Dongen Guus A M S, Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine, 10.1038/nprot.2010.13
  25. Kandil S. A., Scholten B., Saleh Z. A., Youssef A. M., Qaim S. M., Coenen H. H., A comparative study on the separation of radiozirconium via ion-exchange and solvent extraction techniques, with particular reference to the production of 88Zr and 89Zr in proton induced reactions on yttrium, 10.1007/s10967-006-6892-2
  26. Holland Jason P., Sheh Yiauchung, Lewis Jason S., Standardized methods for the production of high specific-activity zirconium-89, 10.1016/j.nucmedbio.2009.05.007
  27. van Dongen G. A.M.S., Visser G. W.M., Lub-de Hooge M. N., de Vries E. G., Perk L. R., Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications, 10.1634/theoncologist.12-12-1379
  28. Vugts Danielle J., van Dongen Guus A.M.S., 89Zr-labeled compounds for PET imaging guided personalized therapy, 10.1016/j.ddtec.2011.12.004
  29. Karmani Linda, Labar Daniel, Valembois Vanessa, Bouchat Virginie, Nagaswaran Praveen Ganesh, Bol Anne, Gillart Jacques, Levêque Philippe, Bouzin Caroline, Bonifazi Davide, Michiels Carine, Feron Olivier, Grégoire Vincent, Lucas Stéphane, Borght Thierry Vander, Gallez Bernard, Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of89Zr-labeled cetuximab in mice : PET IMAGING WITH IMMUNOTARGETED NANOPARTICLES, 10.1002/cmmi.1539
  30. Marega Riccardo, Karmani Linda, Flamant Lionel, Nageswaran Praveen Ganesh, Valembois Vanessa, Masereel Bernard, Feron Olivier, Borght Thierry Vander, Lucas Stephane, Michiels Carine, Gallez Bernard, Bonifazi Davide, Antibody-functionalized polymer-coated gold nanoparticles targeting cancer cells: an in vitro and in vivo study, 10.1039/c2jm33482h
  31. Uneda Shima, Toi Hirofumi, Tsujie Tomoko, Tsujie Masanori, Harada Naoko, Tsai Hilda, Seon Ben K., Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature, 10.1002/ijc.24482
  32. Tsujie Masanori, Tsujie Tomoko, Toi Hirofumi, Uneda Shima, Shiozaki Ken, Tsai Hilda, Seon Ben K., Anti-tumor activity of an anti-endoglin monoclonal antibody is enhanced in immunocompetent mice, 10.1002/ijc.23314
  33. Tsujie, Int. J. Oncol., 29, 1087 (2006)
  34. Takahashi, Cancer Res., 61, 846 (2001)
  35. Tabata Masahiro, Kondo Masao, Haruta Yuro, Seon Ben K., Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using125I-labeled anti-endoglin monoclonal antibodies, 10.1002/(sici)1097-0215(19990827)82:5<737::aid-ijc18>3.0.co;2-8
  36. Matsuno, Clin. Cancer Res., 5, 371 (1999)
  37. Seon, Clin. Cancer Res., 3, 1031 (1997)
  38. Gasparini Giampietro, Longo Raffaele, Fanelli Massimo, Teicher Beverly A., Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open Questions, 10.1200/jco.2005.10.022
  39. Mitchell Dianne C., Bryan Brad A., Anti-angiogenic therapy: Adapting strategies to overcome resistant tumors, 10.1002/jcb.22764
  40. Carmeliet Peter, Jain Rakesh K., Molecular mechanisms and clinical applications of angiogenesis, 10.1038/nature10144
  41. Charpin C., Tumor Neoangiogenesis by CD31 and CD105 Expression Evaluation in Breast Carcinoma Tissue Microarrays, 10.1158/1078-0432.ccr-04-0021
  42. Li C, Gardy R, Seon B K, Duff S E, Abdalla S, Renehan A, O'Dwyer S T, Haboubi N, Kumar S, Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis, 10.1038/sj.bjc.6600874
  43. Tanaka, Clin. Cancer Res., 7, 3410 (2001)
  44. Marioni Gino, Staffieri Alberto, Blandamura Stella, Maspin expression in head and neck carcinoma: subcellular localization matters, 10.1111/j.1600-0714.2009.00868.x
  45. Romani Antonello A., Borghetti Angelo F., Del Rio Paolo, Sianesi Mario, Soliani Paolo, The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count, 10.1002/jso.20456
  46. Kumar, Cancer Res., 59, 856 (1999)
  47. Letamendía Ainhoa, Lastres Pedro, Almendro Nuria, Raab Ulla, Bühring Hans-J., Kumar Shant, Bernabéu Carmelo, Endoglin, a component of the TGF-β receptor system, is a differentiation marker of human choriocarcinoma cells, 10.1002/(sici)1097-0215(19980518)76:4<541::aid-ijc16>3.0.co;2-a
  48. Sun Tao, Sun Bao-cun, Ni Chun-sheng, Zhao Xiu-lan, Wang Xing-hui, Qie Shuo, Zhang Dan-fang, Gu Qiang, Qi Hong, Zhao Nan, Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells, 10.1016/j.canlet.2007.12.015
  49. Hussein Mahmoud R., Transforming growth factor-beta and malignant melanoma: molecular mechanisms, 10.1111/j.0303-6987.2005.00356.x
  50. Yoshitomi Hideyuki, Kobayashi Souichi, Ohtsuka Masayuki, Kimura Fumio, Shimizu Hiroaki, Yoshidome Hiroyuki, Miyazaki Masaru, Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic Cancer : , 10.1097/mpa.0b013e3181690b97
  51. Clasper S., Royston D., Baban D., Cao Y., Ewers S., Butz S., Vestweber D., Jackson D. G., A Novel Gene Expression Profile in Lymphatics Associated with Tumor Growth and Nodal Metastasis, 10.1158/0008-5472.can-07-6506
  52. Wang J. M., Kumar S., Pye D., Krupinski J., Hunter R. D., Van Agthoven A. J., A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues, 10.1002/ijc.2910540303
  53. Fonsatti E., Nicolay H. J.M., Altomonte M., Covre A., Maio M., Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours, 10.1093/cvr/cvp332
  54. Miller Daniel W., Graulich Wolff, Karges Bernadett, Stahl Sabine, Ernst Michael, Ramaswamy Annette, Sedlacek H.-Harald, M�ller Rolf, Adamkiewicz J�rgen, Elevated expression of endoglin, a component of the TGF-?-receptor complex, correlates with proliferation of tumor endothelial cells, 10.1002/(sici)1097-0215(19990517)81:4<568::aid-ijc11>3.0.co;2-x
  55. Burrows, Clin. Cancer Res., 1, 1623 (1995)
  56. Westphal Johan R., Willems Henrica W., Schalkwijk Cornelia J.M., Ruiter Dirk J., de Waal Robert M.W., A New 180-kDa Dermal Endothelial Cell Activation Antigen: In Vitro and In Situ Characteristics, 10.1111/1523-1747.ep12349946
  57. Haruta Y., Seon B. K., Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6., 10.1073/pnas.83.20.7898
  58. Tiwari Pooja, Vig Komal, Dennis Vida, Singh Shree, Functionalized Gold Nanoparticles and Their Biomedical Applications, 10.3390/nano1010031
  59. Glazer Evan S., Massey Katheryn L., Zhu Cihui, Curley Steven A., Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles, 10.1016/j.surg.2010.04.025
  60. Mallidi Srivalleesha, Larson Timothy, Aaron Jesse, Sokolov Konstantin, Emelianov Stanislav, Molecular specific optoacoustic imaging with plasmonic nanoparticles, 10.1364/oe.15.006583
  61. Dykman Lev, Khlebtsov Nikolai, Gold nanoparticles in biomedical applications: recent advances and perspectives, 10.1039/c1cs15166e
  62. Julien Daniel C., Behnke Steven, Wang Guankui, Murdoch Gordon K., Hill Rodney A., Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer, 10.4161/mabs.3.5.16089